Upgrade to SI Premium - Free Trial

Abbott Labs (ABT) PT Lowered to $110; Bernstein: 'Good entry point, or value trap?'

April 20, 2026 7:23 AM
Bernstein SocGen Group analyst Lee Hambright lowered the price target on Abbott Labs (NYSE: ABT) to $110.00 (from $125.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change